Market Cap: $644.33B
JJ
Johnson & Johnson
JNJ
NYSE (New York Stock Exchange)USD
Market Cap: $644.33B
Johnson & Johnson (JNJ) has been making significant strides in refocusing its business strategy towards oncology, highlighted by groundbreaking product innovations and strategic acquisitions aimed at…
Johnson & Johnson (Ticker: JNJ) positions itself as a front-runner in the oncology landscape with significant strides regarding its cancer treatment innovation. The European Medicines Agency’s committ…
Johnson & Johnson (Ticker: JNJ) presents new encouraging data on IMAAVY® (nipocalimab-aahu), showcasing its potential in treating generalized myasthenia gravis (gMG) at the European Academy of Neurolo…
Johnson & Johnson (Ticker: JNJ) is undergoing a notable transformation in its strategic priorities as it shifts focus from the obesity drug market to cancer treatments. This decision underscores the c…
Open
$260.225
Prev. Close
$260.35
High
$261.38
Low
$255.93